Forsta Ap Fonden Pfizer Inc Transaction History

Forsta Ap Fonden

$12.8 Billion
Q3 2024

A detailed history of Forsta Ap Fonden transactions in Pfizer Inc stock. As of the latest transaction made, Forsta Ap Fonden holds 1,421,400 shares of PFE stock, worth $39 Million. This represents 0.32% of its overall portfolio holdings.

Number of Shares

1,421,400

Previous 1,282,600 10.82%

Holding current value

$39 Million

Previous $35.9 Million 14.62%

% of portfolio

0.32%

Previous 0.32%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 24, 2024	BUY	$27.7 - $31.39 $3.84 Million - $4.36 Million	138,800 Added 10.82%	1,421,400 $41.1 Million
Q2 2024 Aug 08, 2024	SELL	$25.26 - $29.6 $2.05 Million - $2.4 Million	-81,100 Reduced 5.95%	1,282,600 $35.9 Million
Q1 2024 May 07, 2024	SELL	$25.89 - $29.73 $6.03 Million - $6.93 Million	-233,000 Reduced 14.59%	1,363,700 $37.8 Million
Q4 2023 Feb 06, 2024	BUY	$26.13 - $33.94 $616,668 - $800,984	23,600 Added 1.5%	1,596,700 $46 Million
Q3 2023 Oct 25, 2023	BUY	$32.09 - $37.51 $1.6 Million - $1.87 Million	49,900 Added 3.28%	1,573,100 $52.2 Million
Q2 2023 Aug 03, 2023	BUY	$36.12 - $41.79 $184,212 - $213,129	5,100 Added 0.34%	1,523,200 $55.9 Million
Q1 2023 Apr 21, 2023	SELL	$39.39 - $51.28 $5.43 Million - $7.07 Million	-137,900 Reduced 8.33%	1,518,100 $61.9 Million
Q4 2022 Feb 02, 2023	BUY	$41.75 - $54.5 $11.1 Million - $14.5 Million	266,000 Added 19.14%	1,656,000 $84.9 Million
Q3 2022 Oct 17, 2022	BUY	$43.76 - $53.42 $13.2 Million - $16.1 Million	301,600 Added 27.71%	1,390,000 $60.8 Million
Q2 2022 Aug 11, 2022	BUY	$46.53 - $55.17 $2.2 Million - $2.6 Million	47,200 Added 4.53%	1,088,400 $57.1 Million
Q1 2022 May 09, 2022	SELL	$45.75 - $56.69 $5.63 Million - $6.97 Million	-123,000 Reduced 10.57%	1,041,200 $53.9 Million
Q4 2021 Feb 11, 2022	BUY	$41.32 - $61.25 $1.52 Million - $2.25 Million	36,800 Added 3.26%	1,164,200 $68.7 Million
Q3 2021 Nov 10, 2021	SELL	$39.25 - $50.42 $596,600 - $766,384	-15,200 Reduced 1.33%	1,127,400 $48.5 Million
Q2 2021 Aug 12, 2021	BUY	$35.91 - $40.68 $5.25 Million - $5.95 Million	146,200 Added 14.67%	1,142,600 $44.7 Million
Q1 2021 May 11, 2021	BUY	$33.49 - $37.77 $709,988 - $800,724	21,200 Added 2.17%	996,400 $36.1 Million
Q4 2020 Feb 09, 2021	BUY	$33.47 - $42.56 $7.31 Million - $9.3 Million	218,400 Added 28.86%	975,200 $35.9 Million
Q3 2020 Oct 22, 2020	SELL	$31.75 - $37.25 $2.53 Million - $2.97 Million	-79,700 Reduced 9.53%	756,800 $27.8 Million
Q2 2020 Aug 11, 2020	BUY	$30.12 - $36.54 $2.24 Million - $2.71 Million	74,300 Added 9.75%	836,500 $27.4 Million
Q1 2020 May 04, 2020	BUY	$27.03 - $38.62 $20.6 Million - $29.4 Million	762,200 New	762,200 $24.9 Million
Q4 2019 Feb 12, 2020	SELL	$32.92 - $37.36 $3.67 Million - $4.16 Million	-111,400 Closed	0 $0
Q3 2019 Nov 13, 2019	BUY	$32.49 - $42.13 $711,531 - $922,647	21,900 Added 24.47%	111,400 $4 Million
Q2 2019 Aug 07, 2019	SELL	$36.98 - $41.52 $465,947 - $523,152	-12,600 Reduced 12.34%	89,500 $3.88 Million
Q1 2019 May 08, 2019	SELL	$37.5 - $41.2 $101,250 - $111,240	-2,700 Reduced 2.58%	102,100 $4.34 Million
Q4 2018 Feb 11, 2019	SELL	$38.47 - $43.86 $1.34 Million - $1.53 Million	-34,800 Reduced 24.93%	104,800 $4.58 Million
Q3 2018 Nov 07, 2018	BUY	$34.47 - $41.81 $3.81 Million - $4.62 Million	110,500 Added 379.73%	139,600 $6.15 Million
Q2 2018 Aug 15, 2018	SELL	$32.98 - $35.16 $16.4 Million - $17.5 Million	-497,014 Reduced 94.47%	29,100 $1.06 Million
Q1 2018 May 09, 2018	SELL	$31.91 - $37.02 $427,594 - $496,068	-13,400 Reduced 2.48%	526,114 $18.7 Million
Q4 2017 Feb 08, 2018	BUY	$33.26 - $35.29 $2.76 Million - $2.93 Million	83,000 Added 18.18%	539,514 $19.5 Million
Q3 2017 Oct 31, 2017	BUY	$31.0 - $34.15 $14.2 Million - $15.6 Million	456,514	456,514 $16.3 Million

Others Institutions Holding PFE

# of Institutions

3,253

Shares Held

3.72B

Call Options Held

73.5M

Put Options Held

108M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $154B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Forsta Ap Fonden, based on Form 13F filings with the SEC.

News

Stay updated on Forsta Ap Fonden with notifications on news.

Account